{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:36:05Z","timestamp":1793262965532,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015549","name":"Vietnam National University Science & Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.104085","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:22:16Z","timestamp":1792682536000},"page":"104085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Caveolin-1 is associated with acquired selumetinib resistance and altered EGFR signaling in colorectal cancer cells"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-9826","authenticated-orcid":false,"given":"Hong-Quan","family":"Duong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong-Thoa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van-Thu","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van-Lang","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Thu-Phuong","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Chinh","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Yen-Thu","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Phuong-Oanh","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Thu-Ha","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Tuyet-Chinh","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Linh-Chi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Ngoc-Ha","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"The-Hung","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.104085_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00401-006-0097-1","article-title":"Caveolin-1 in meningiomas: expression and clinico-pathological correlations","volume":"112","author":"Barresi","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tice.2026.104085_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijc.28001","article-title":"Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis","volume":"133","author":"Basu Roy","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2026.104085_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00001813-200304000-00005","article-title":"Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells","volume":"14","author":"B\u00e9langer","year":"2003","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.tice.2026.104085_bib4","first-page":"5870","article-title":"Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of Caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity","volume":"60","author":"Bender","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2026.104085_bib5","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1158\/0008-5472.CAN-06-4697","article-title":"Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and Met signaling","volume":"67","author":"Cantiani","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2026.104085_bib6","article-title":"Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: a mini-review","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.tice.2026.104085_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/atm-20-3293","article-title":"Caveolin-1 promotes radioresistance via IRGM-regulated autophagy in lung cancer","volume":"9","author":"Chen","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.tice.2026.104085_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.02.005","article-title":"Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair","volume":"505","author":"Codenotti","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2026.104085_bib9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3892\/ijo.2012.1516","article-title":"Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells","volume":"41","author":"Duong","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tice.2026.104085_bib10","first-page":"182","article-title":"ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine","volume":"27","author":"Duong","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tice.2026.104085_bib11","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1158\/0008-5472.CAN-17-3149","article-title":"The endosomal protein CEMIP links WNT signaling to MEK1\u2013ERK1\/2 activation in Selumetinib-resistant intestinal organoids","volume":"78","author":"Duong","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2026.104085_bib12","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1210\/en.2008-1344","article-title":"Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells","volume":"150","author":"Fiori","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.tice.2026.104085_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mog2.70","article-title":"The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy","volume":"3","author":"Ge","year":"2024","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.tice.2026.104085_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neo.2014.08.011","article-title":"Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation","volume":"16","author":"Grasso","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.tice.2026.104085_bib15","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3390\/ijms26051988","article-title":"Mechanisms and strategies to overcome drug resistance in colorectal cancer","volume":"26","author":"Haynes","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.104085_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10238-021-00783-z","article-title":"Selumetinib: a selective MEK1 inhibitor for solid tumor treatment","volume":"23","author":"Hedayat","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.tice.2026.104085_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2009.07.004","article-title":"Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells","volume":"92","author":"Hehlgans","year":"2009","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.tice.2026.104085_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12943-026-02704-8","article-title":"Deconstructing cancer in 3D: Models, mechanisms, and personalized solutions","volume":"25","author":"Huang","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2026.104085_bib19","series-title":"GLOBOCAN 2024: Viet Nam Fact Sheet","author":"International Agency for Research on Cancer (IARC)","year":"2026"},{"key":"10.1016\/j.tice.2026.104085_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/cncr.10329","article-title":"Overexpression of Caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage","volume":"94","author":"Kato","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.tice.2026.104085_bib21","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/ijc.31369","article-title":"Caveolin-1, cancer and therapy resistance","volume":"143","author":"Ketteler","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2026.104085_bib22","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.onc.1201661","article-title":"Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells","volume":"16","author":"Lee","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.tice.2026.104085_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258951","article-title":"Role of Caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer","volume":"16","author":"Leiser","year":"2021","journal-title":"PLoS. One"},{"key":"10.1016\/j.tice.2026.104085_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tice.2026.104085_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/ol.2016.5390","article-title":"Downregulation of Caveolin-1 increases the sensitivity of drug-resistant colorectal cancer HCT116 cells to 5-fluorouracil","volume":"13","author":"Li","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tice.2026.104085_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2^\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.tice.2026.104085_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188447","article-title":"Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside","volume":"1874","author":"Lizardo","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tice.2026.104085_bib28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40265-020-01331-x","article-title":"Selumetinib: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.tice.2026.104085_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biopha.2010.03.006","article-title":"GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells","volume":"64","author":"Miao","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tice.2026.104085_bib30","series-title":"Defining cancer","author":"National Cancer Institute","year":"2026"},{"key":"10.1016\/j.tice.2026.104085_bib31","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.tice.2026.104085_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000456620","article-title":"Correlation of Caveolin-1 expression with prognosis in patients with gastric cancer after gastrectomy","volume":"40","author":"Seker","year":"2017","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.tice.2026.104085_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7150\/jca.6470","article-title":"Identification of Caveolin-1 as a potential causative factor in the generation of trastuzumab resistance in breast cancer cells","volume":"4","author":"Sekhar","year":"2013","journal-title":"J. Cancer"},{"key":"10.1016\/j.tice.2026.104085_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10555-020-09890-x","article-title":"Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer","volume":"39","author":"Sim\u00f3n","year":"2020","journal-title":"Cancer Metastas Rev."},{"key":"10.1016\/j.tice.2026.104085_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/annonc\/mdi057","article-title":"Epidermal growth factor receptor signaling in colorectal cancer: Preclinical data and therapeutic perspectives","volume":"16","author":"Spano","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tice.2026.104085_bib36","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tice.2026.104085_bib37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1159\/000430292","article-title":"Caveolin-1 confers resistance of hepatoma cells to anoikis by activating IGF-1 pathway","volume":"36","author":"Tang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tice.2026.104085_bib38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s12032-011-9900-5","article-title":"Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer","volume":"29","author":"Tang","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.tice.2026.104085_bib39","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3748\/wjg.v29.i6.926","article-title":"Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments","volume":"29","author":"Tang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tice.2026.104085_bib40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/0008-5472.CAN-10-0730","article-title":"Src and Caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer","volume":"71","author":"Thomas","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2026.104085_bib41","article-title":"Fexofenadine overcomes osimertinib resistance by inhibiting c-Met in non-small cell lung cancer","volume":"4","author":"To","year":"2025","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.tice.2026.104085_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/path.3957","article-title":"Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis","volume":"226","author":"Tse","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.tice.2026.104085_bib43","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","article-title":"MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors","volume":"72","author":"Turke","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2026.104085_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2020.00046","article-title":"Caveolin-1 promotes chemoresistance of gastric cancer cells to cisplatin by activating WNT\/\u03b2-catenin pathway","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2026.104085_bib45","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/carcin\/bgu155","article-title":"Caveolin-1 mediates chemoresistance in breast cancer stem cells via \u03b2-catenin\/ABCG2 signaling pathway","volume":"35","author":"Wang","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tice.2026.104085_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0014-5793(98)01354-4","article-title":"Upregulation of Caveolin-1 and caveolae organelles in Taxol-resistant A549 cells","volume":"439","author":"Yang","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tice.2026.104085_bib47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.12659\/MSM.907782","article-title":"Caveolin-1 inhibits proliferation, migration, and invasion of human colorectal cancer cells by suppressing phosphorylation of epidermal growth factor receptor","volume":"24","author":"Yang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.tice.2026.104085_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.12046","article-title":"Inhibition of the PI3K\/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells","volume":"17","author":"Yi","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tice.2026.104085_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232235","article-title":"Clinicopathological and prognostic significance of Caveolin-1 and ATG4C expression in the epithelial ovarian cancer","volume":"15","author":"Zeng","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.tice.2026.104085_bib50","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1159\/000485291","article-title":"Knockdown of CAVEOLIN-1 sensitizes human basal-like triple-negative breast cancer cells to radiation","volume":"44","author":"Zou","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tice.2026.104085_bib51","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.3892\/or.2015.4320","article-title":"Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1\/Akt\/NF-\u03baB pathway","volume":"34","author":"Zou","year":"2015","journal-title":"Oncol. Rep."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626007810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626007810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:12:16Z","timestamp":1793261536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626007810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":51,"alternative-id":["S0040816626007810"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.104085","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caveolin-1 is associated with acquired selumetinib resistance and altered EGFR signaling in colorectal cancer cells","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.104085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104085"}}